Pfizer Inc (PFE)

47.475
+2.075(+4.57%)
  • Volume:
    646,431
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    44.180 - 48.615
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035
  • WKN:852009

PFE Overview

Prev. Close
45.4
Day's Range
44.18-48.615
Revenue
61.26B
Open
45.055
52 wk Range
27.52-48.615
EPS
-
Volume
646,431
Market Cap
267.75B
Dividend (Yield)
1.33
(2.93%)
Average Vol. (3m)
99,632
P/E Ratio
15.86
Beta
-
1-Year Change
54.14%
Shares Outstanding
5,612,866,598
Next Earnings Date
Feb 01, 2022
What is your sentiment on Pfizer Inc?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc Company Profile

Employees
78500

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong BuyStrong Buy
SummaryStrong SellSellStrong BuyStrong BuyStrong Buy
  • $200 per share target
    1
    • Ply
      0
      • The first jab work for 100% great lie, you can not be in Hospital, now half in Hospital vaccinated
        13
        • Ford 🍌🍌🍑. REPORT HIM!
          1
      • Easy double from here
        4
        • https://money.cnn.com/quote/forecast/forecast.html?symb=PFEHold for nowBest case 61
          1
          • buy and hold
            1
            • soon less all out
              5
              • 40 again
                11
                • Never
                  1
                • That would be nice !! I wish I can all in and buy more so cheap....
                  0
              • 80 soon
                0
                • Should have been 150
                  0
                • dont scare Ray and Ford...let them have a peaceful thanksgiving
                  1
                • give me help plz im indian u give me advice what's stock news today
                  0
              • insider on stocks that will rise in price by 35% bery, pba, dhr, bll, tdg!
                0
                • that was odd stretch on the weekly chart my bet is up we go
                  3
                  • pfizer may dip when it hits 55 to 60, and come back to 50, so you guys can hedge a little bit when you recognise the trend, right Mr Ford
                    3
                    • unvaccinated ban they can not longer eat in shopping malls or market
                      2
                      • This is the dip!!!
                        0
                        • Ray Ray Ray
                          3
                          • 🍑🍌🍌
                            0
                        • Now.. go to the moon
                          1
                          • Its Lunch time bois, lets sell the top and buy the dip and hold for the run🥂
                            0
                            • How dip that u think?
                              0
                            • Happy Holidays. Enjoy 🥂
                              0
                            • This is the dip!!!
                              0
                          • Jesus, more lockdowns here in Europe, Europe is in chaos, the MRNA vaccine has failed, doesnt hold up at all, this is the perfect time for Novavax to sweep the floor and save us all!
                            2
                            • ray is silent?????
                              0
                              • 😂😂😂😂😂😂
                                0
                              • He's busy cooking up the next conspiracies!
                                0
                            • Up to 55-60-75...120
                              0
                              • You miss the train if you sell, look at prices of the others….
                                0
                                • But analysts predict 61. I would not be so sure
                                  2
                                  • Time to sell i think
                                    7
                                    • $60 within couple of days
                                      0
                                  • Well now, we all know it's only fun to brag,,,when we are right. 😉
                                    0
                                    • tomorrow pop or drop it's one or the other should be big
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.